LivaNova (LIVN) Other Non-Current Liabilities (2015 - 2026)
LivaNova recorded quarterly Other Non-Current Liabilities of $54.4 million in Q1 2026, up 29.34% quarter-over-quarter from $42.0 million in Q4 2025, and down 36.13% year-over-year from $85.1 million in Q1 2025.
LivaNova's Other Non-Current Liabilities history runs 12 years deep, the most recent figure standing at $54.4 million for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities fell 36.13% year-over-year to $54.4 million; the TTM figure through Mar 2026 stood at $54.4 million (down 36.13% YoY), while the FY2025 annual figure was $42.0 million, down 5.47% from the prior year.
- Other Non-Current Liabilities came in at $54.4 million for Q1 2026 at LivaNova, up from $42.0 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $134.1 million in Q2 2022 to a low of $42.0 million in Q4 2025.
- A 5-year average of $75.1 million and a median of $80.9 million in 2023 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities surged 74.56% in 2024 and plunged 50.01% in 2025, its largest moves.
- LivaNova's Other Non-Current Liabilities stood at $91.6 million in 2022, then retreated by 11.64% to $80.9 million in 2023, then plunged by 45.02% to $44.5 million in 2024, then fell by 5.47% to $42.0 million in 2025, then advanced by 29.34% to $54.4 million in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $54.4 million, $42.0 million, and $64.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.38 Mn |
| Dec 31, 2025 | 42.05 Mn |
| Sep 30, 2025 | 64.52 Mn |
| Jun 30, 2025 | 52.70 Mn |
| Mar 31, 2025 | 85.14 Mn |
| Dec 31, 2024 | 44.48 Mn |
| Sep 30, 2024 | 84.16 Mn |
| Jun 30, 2024 | 105.41 Mn |
| Mar 31, 2024 | 80.77 Mn |
| Dec 31, 2023 | 80.90 Mn |
| Sep 30, 2023 | 53.30 Mn |
| Jun 30, 2023 | 92.63 Mn |
| Mar 31, 2023 | 46.27 Mn |
| Dec 31, 2022 | 91.56 Mn |
| Sep 30, 2022 | 81.85 Mn |
| Jun 30, 2022 | 134.09 Mn |
| Mar 31, 2022 | 83.34 Mn |
| Dec 31, 2021 | 86.83 Mn |
| Jun 30, 2021 | 97.05 Mn |
| Mar 31, 2021 | 148.28 Mn |
| Dec 31, 2020 | 57.62 Mn |
| Sep 30, 2020 | 59.59 Mn |
| Jun 30, 2020 | 71.50 Mn |
| Mar 31, 2020 | 99.73 Mn |
| Dec 31, 2019 | 114.40 Mn |
| Sep 30, 2019 | 13.92 Mn |
| Jun 30, 2019 | 133.07 Mn |
| Mar 31, 2019 | 147.08 Mn |
| Dec 31, 2018 | 27.90 Mn |
| Sep 30, 2018 | 164.61 Mn |
| Jun 30, 2018 | 39.60 Mn |
| Mar 31, 2018 | 183.98 Mn |
| Dec 31, 2017 | 35.11 Mn |
| Sep 30, 2017 | 74.40 Mn |
| Jun 30, 2017 | 75.67 Mn |
| Mar 31, 2017 | 37.76 Mn |
| Dec 31, 2016 | 35.07 Mn |
| Sep 30, 2016 | 27.17 Mn |
| Jun 30, 2016 | 29.61 Mn |
| Mar 31, 2016 | 31.81 Mn |
| Dec 31, 2015 | 29.74 Mn |
| Apr 24, 2015 | 6.61 Mn |